For Funds Close to Empty, Filling Stations May Be Hard to Find
This article was originally published in Start Up
Executive Summary
VCs that need to raise money in 2009 or 2010 may find the going rough. Here we chart out when life sciences VCs raised their last funds.
You may also be interested in...
As Some VCs Run On Empty, Others Are Topping Off The Tank
New money is increasingly hard to come by for life sciences venture capital firms. Start-Up tracks VCs to determine which firms have older vintage funds and which have plenty of fresh capital to invest.
As Some VCs Run On Empty, Others Are Topping Off The Tank
New money is increasingly hard to come by for life sciences venture capital firms. Start-Up tracks VCs to determine which firms have older vintage funds and which have plenty of fresh capital to invest.
Boehringer Ingelheim Joins The Corporate Venture Party
In late March, Boehringer Ingelheim GMBH formally unveiled its $134 million corporate venture fund, a strategically-focused effort that will invest in areas believed to be important to the privately-held German pharma's future growth, including RNA silencing, stem cells, and next generation vaccine, protein, and antibody technologies.